The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 5, 1996, Pages 993-998

  Xiong, Y Q ^a   Caillon, J ^a   Drugeon, H ^a   Potel, G ^a   Baron, D ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; NETILMICIN; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; DRUG POTENTIATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ADAPTATION, PHYSIOLOGICAL; AMINOGLYCOSIDES; ANTIBIOTICS, ANTITUBERCULAR; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; RIFAMPIN;

EID: 0029896104     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.5.993     Document Type: Article

References (11)

1. Barclay, M. L., Begg, E. J. & Chambers, S. T. (1992). Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrobial Agents and Chemotherapy 36, 1951-7.
2. Daikos, G. L., Jackson, G. G., Lolans, V. T. & Livermore, D. M. (1990). Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. Journal of Infectious Diseases 162, 414-20.
3. Daikos, G. L., Lolans, V. A. & Jackson, G. G. (1991). First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optical clinical use. Antimicrobial Agents and Chemotherapy 35, 117-23.
4. Dougherty, P. F., Yotter, D. W. & Matthews, T. R. (1977). Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents. Antimicrobial Agents and Chemotherapy 11, 225-8.
5. Drugeon, H. B., Juvin, M. E., Pirault, J. L. & Dellamonica, P. (1988). Bactericidal activity of pefloxacin in combination with rifampicin, fosfomycin and vancomycin against Staphylococcus aureus: determination by a dynamic method. Reviews of Infectious Diseases 10, Suppl. 1, 80-1.
6. Drugeon, H. B., Le Gallou, F. & Caillon, J. (1990). Méthodes d'étude de l'activité bactéricide. In Bactéricidie, Aspects Theoriques et Thérapeutiques (Courvalin, P., Drugeon, H., Flandrios, J. P. & Goldstein, F., Eds), pp. 113-26. Maloine, Paris.
7. +-ATPase inhibitor. In Programs and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract C29. American Society for Microbiology, Washington, DC.
8. Valdes, J. M., Baltch, A. L., Smith, R. P., Hammer, M. C., & Ritz, W. J. (1990). The effect of rifampicin on the in vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 25, 575-84.
9. Xiong, Y. Q., Caillon, J., Drugeon, H., Potel, G. & Baron, D. (1996). Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their post-antibiotic effects. Antimicrobial Agents and Chemotherapy 40, 35-9.
10. Zuravleff, J. J., Chervenick, P., Yu, V. L., Muder, R. R. & Diven, W. F. (1984). Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infection: assessment in a neutropenic mouse model. Journal Laboratory Clinical Medicine 103, 878-85.
11. Zuravleff, J. J., Yu, V. L. & Yee, R. B. (1983). Ticarcillin-tobramycin-rifampin: in vitro synergy of the triple combination against Pseudomonas aeruginosa. Journal Laboratory Clinical Medicine 101, 896-902.